As of 2025-05-18, the EV/EBITDA ratio of Health Advance Inc (HADV) is -2.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HADV's latest enterprise value is 0.16 mil USD. HADV's TTM EBITDA according to its financial statements is -0.08 mil USD. Dividing these 2 quantities gives us the above HADV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 8.2x | 7.4x |
| Forward P/E multiples | 8.8x - 9.6x | 9.2x |
| Fair Price | (0.00) - 0.00 | (0.00) |
| Upside | -987.9% - 12.6% | -585.5% |
| Date | EV/EBITDA |
| 2025-05-16 | -2.04 |
| 2025-05-15 | -2.04 |
| 2025-05-14 | -2.04 |
| 2025-05-13 | -2.45 |
| 2025-05-12 | -2.04 |
| 2025-05-09 | -2.04 |
| 2025-05-08 | -2.45 |
| 2025-05-07 | -2.45 |
| 2025-05-06 | -2.45 |
| 2025-05-05 | -2.45 |
| 2025-05-02 | -2.45 |
| 2025-05-01 | -2.65 |
| 2025-04-30 | -2.65 |
| 2025-04-29 | -2.65 |
| 2025-04-28 | -2.24 |
| 2025-04-25 | -2.24 |
| 2025-04-24 | -2.24 |
| 2025-04-23 | -2.24 |
| 2025-04-22 | -2.24 |
| 2025-04-16 | -2.24 |
| 2025-04-15 | -2.45 |
| 2025-04-14 | -2.04 |
| 2025-04-11 | -1.84 |
| 2025-04-10 | -2.04 |
| 2025-04-08 | -2.04 |
| 2025-04-07 | -2.24 |
| 2025-04-04 | -2.04 |
| 2025-04-03 | -1.84 |
| 2025-04-02 | -1.84 |
| 2025-04-01 | -1.84 |
| 2025-03-31 | -1.84 |
| 2025-03-28 | -2.04 |
| 2025-03-27 | -2.04 |
| 2025-03-26 | -2.04 |
| 2025-03-25 | -2.04 |
| 2025-03-24 | -2.04 |
| 2025-03-21 | -1.84 |
| 2025-03-20 | -2.04 |
| 2025-03-19 | -2.04 |
| 2025-03-18 | -1.84 |
| 2025-03-17 | -2.04 |
| 2025-03-13 | -2.04 |
| 2025-03-12 | -2.04 |
| 2025-03-11 | -2.04 |
| 2025-03-10 | -2.04 |
| 2025-03-07 | -2.04 |
| 2025-03-05 | -2.04 |
| 2025-03-03 | -2.04 |
| 2025-02-28 | -2.24 |
| 2025-02-27 | -2.65 |